These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6541921)

  • 21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of osteoporosis with fluoride, calcium, and vitamin D.
    Briancon D; Meunier PJ
    Orthop Clin North Am; 1981 Jul; 12(3):629-48. PubMed ID: 7290589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fluorine-calcium combination for the treatment of osteoporosis].
    Meffert O; Kämmerer H; Reichelt A; Olschinka J
    Med Welt; 1975 May; 26(22):1101-4. PubMed ID: 1143081
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioavailability of monofluoride preparations for dental caries prophylaxis (author's transl)].
    Fuchs C; Férault-Larue DH; Heimann G
    Arzneimittelforschung; 1980; 30(2):333-5. PubMed ID: 7378115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of primary osteoporosis with sodium fluoride and calcium].
    Ringe JD; Kruse HP; Kuhlencordt F
    Med Klin; 1982 Jan; 77(3):46-9. PubMed ID: 7057731
    [No Abstract]   [Full Text] [Related]  

  • 30. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
    Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
    J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers.
    Rasmussen BB; Larsen LS; Senderovitz T
    BJOG; 2005 Nov; 112(11):1492-9. PubMed ID: 16225568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.
    Warneke G; Setnikar I
    Arzneimittelforschung; 1993 May; 43(5):590-5. PubMed ID: 8329005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of concurrent calcium ingestion on intestinal absorption of fluoride.
    Jowsey J; Riggs BL
    Metabolism; 1978 Aug; 27(8):971-4. PubMed ID: 672616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pros and cons of sodium fluoride therapy in osteoporosis].
    Zippel C; Rempel H; Schmidt UJ
    Z Alternsforsch; 1975; 30(2):173-9. PubMed ID: 1226822
    [No Abstract]   [Full Text] [Related]  

  • 35. [Circadian-induced change in the pharmacokinetic pattern exemplified on hexobarbital/Retrospective analysis of experimental data (author's transl)].
    Altmayer P; Lücker PW; Rindt W
    Arzneimittelforschung; 1979; 29(10):1633-5. PubMed ID: 583232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic studies of fluoride treatment for osteoporosis].
    Fuchs C; Heimann G; Scheler F
    Verh Dtsch Ges Inn Med; 1978; (84):1119-21. PubMed ID: 741901
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined treatment of primary osteoporosis with oral sodium fluoride, estrogens and calcium.
    Zanzi I; Aloia JF; Ellis KJ; Cohn SH
    Calcif Tissue Res; 1977 May; 22 Suppl():563. PubMed ID: 578781
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes of calciuria and phosphaturia caused by prolonged treatment with sodium fluoride in senile osteoporosis].
    Cesari L; Borghesi R; Medaglini E
    Boll Soc Ital Biol Sper; 1969 Apr; 45(8):482-3. PubMed ID: 5369738
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoride pharmacokinetics in the domestic pig.
    Richards A; Fejerskov O; Ekstrand J
    J Dent Res; 1982 Sep; 61(9):1099-102. PubMed ID: 6963284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of fluoride in man after single and multiple oral doses.
    Ekstrand J; Alván G; Boréus LO; Norlin A
    Eur J Clin Pharmacol; 1977 Dec; 12(4):311-7. PubMed ID: 590317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.